Advantages of Legalizing the Sale of Human Organs

Patients would be compensated with the price of their organs. For example, Mr. Drak, who had sold his organ in Iran – the only country that has legalized the sale of human organs – was compensated between $2,000 and $4,000 for his kidney. This compensation could improve their financial situation and their standard of living. Donor-seller follow-up treatment would also be consistent with guidelines established by the government. The fear of having complications after surgery would then decrease. The donor is certainly healthy and healthy. The lack of human organs persists in today`s society. However, no concrete solutions have been implemented to at least reduce the problem. Currently, legalizing the sale of human organs for transplantation is the obvious solution to the problem.

However, the solution faces a lot of criticism, not least because of its immorality and negativity about how the solution is currently perceived. Only with proper and correct information, information and education could the problem be solved. As Robert Berman once quoted, “The choice we face is not between buying or not buying organs. This happens regardless of the law. The choice is whether transplants and the sale of organs are regulated or not. The lack of organs carries the great danger of preventable deaths. This is a problem not only in the UK, but around the world. An immediate solution? Legalize the sale of organs. By legalizing the sale of kidneys from living donors, Iran was able to avoid these black market traps, and today about 55 percent of all kidney donated in the country comes from living donors, according to government statistics obtained from The Associated Press.

In comparison, only about 38% of kidney donations in the United States come from living donors. The rest comes from deceased donors, and these organs are not so likely to keep recipients healthy in the long run. The government regulates the business sector in each country. And in legalizing the sale of human organs, taxation wants to be included in the transaction. Taxation stimulates the country`s economic activity and could help in the development and implementation of government projects, as well as the compensation of the donor-seller in case of emergency. Justice requires that every human being has an equal right to life. To protect this right, society has a duty to ensure that every person, rich or poor, has equal access to medical services. But if a market for organs were to develop, solvency would determine who could buy organs, while economic necessity would determine who would be motivated to sell their organs. The very rich would end up being buyers of the organs sold by the very poor. An organ market would thus benefit the rich while putting pressure on the poor to endanger their own health. Such an unequal distribution of health benefits and burdens would be unfair.

However, the population that provides the organs is not like the people who receive them. GFI researchers found that kidney buyers tend to be middle- to high-income people from developed countries, while kidney sellers tend to come from the world`s most vulnerable populations. For poor and uneducated citizens in developing countries, selling a kidney may be the only way to escape poverty or pay debt. The legal sale of organs will also lead to a reduction in the NHS burden. While waiting for kidney transplants, patients need dialysis, an expensive daily treatment that costs the NHS. It has been calculated that each kidney transplant saves the NHS over £200,000. The higher the number of kidney recipients, the less dialysis treatments are required. Individuals will also be motivated to stay healthy to get a higher price for their organs. This benefits not only the individual (both in terms of health and financial benefits), but also the country as a whole, as less preventable diseases such as obesity or smoking-related diseases need to be treated in the NHS. Many people find the sale of organs morally reprehensible. But keep in mind that today, every person in the operating room is compensated during a transplant – with the exception of the donor. Doctors and nurses are paid for their skills, as are the people who clean up after the procedure.

The recipient is of course “paid” with a new organ. It seems strange that the person who offers the most important of all, his organ, is the only one who is not remunerated. Proponents of the organ sale system argue that we have a moral duty to save lives and reduce human suffering when it is within our power to do so. Thousands and thousands of patients die every year simply because of an insufficient supply of organs. Patients who need kidneys wait for years in the hope of donors as they undergo painful and expensive dialysis treatments. The approval of a commercial market for organs could put an end to unnecessary death and suffering by increasing the supply of organs. It is clear that cash payments increase people`s willingness to “donate” body parts, thereby increasing supply. Just look at the success of commercial markets in increasing the supply of blood and sperm. Given the large number of people who would be willing to part with their organs for a price, those who need organs are much more likely to get healthier or better matched organs, which increases the number of successful transplants. Up to 70% of transplanted kidneys are likely to fail in the next 10 years, but these weak long-term prospects could be greatly improved if donors were better targeted at recipients. Finally, by increasing the supply of organs, the market mechanism will eventually drive down the price of organs so that more people can afford them. The really decent way would be to allow people to hold or release their organs, especially after death, even if they are against the money.

Thousands of lives would be saved. Again, humanitarianism is best served by respect for civil liberties, and yet we are both deprived, with terribly unfortunate consequences, just to maintain the appearance of state-imposed decency. Although organ transplantation has become a vital wonder of modern medicine, donor waiting lists are much longer than care, and many patients die before they can be treated. Proponents therefore argue that creating an economic incentive for organ donation will save lives. However, others argue that allowing the sale of organ harvesting would reduce equitable access between rich and poor and promote illegal organ trafficking in developing countries. Should the market for human organs be legalized? This series of events doesn`t seem so dramatic given that in 2011, there were 90,363 candidates on the waiting list for a kidney transplant in the United States, but only 16,855 surgeries. Since then, the gap between the number of people who need a kidney and the available kidneys has widened. America needs a more efficient solution, and to create a legalized market for living organs, organs such as kidneys or sections of the liver, than what can be removed when the donor is still alive, it could be. Yet the act of exchanging money for organs is illegal everywhere in the world, with the exception of Iran. Kidneys are the most commonly sold organs for a fairly simple reason: people have two and can live a healthy life with only one. The sale of kidneys may therefore seem like a simple matter of supply and demand – the demand for kidneys is high, so voluntary donors should theoretically be able to negotiate their price from a position of strength.

According to the United Network for Organ Sharing (UNOS), about 115,000 patients need an organ transplant. These patients are victims of a failing organ and are placed directly on a waiting list for all available organs. However, only 3000 patients receive organ transplants from donors, while the rest patients die before receiving the organ. The current scenario clearly reflects the lack of human organs for transplantation. This problem has been widespread in recent years and only one likely solution has been offered to the public – the legal sale of human organs. In 2016, legally donated organs covered less than 10 percent of global needs, according to a report by the Global Observatory on Donation and Transplantation, the world`s most comprehensive source of transplant data. In 2014, 4,761 Americans died and waited for a kidney transplant, and another 3,668 fell off the list because they became too ill to receive one, notes the National Kidney Foundation (NKF), an organization dedicated to raising awareness, preventing and treating kidney disease. Stanford. (2015, October 22).

The sale of human organs. Retrieved February 6, 2018, from the Standford Encyclopedia of Philosophy: Smith, L. (January 5, 2011). The sale of human organs should be legalized, surgeons say. Accessed February 6, 2018 by The Independent: Although the sale of human organs has legitimate reasons to be dismissed as a solution to the problem of organ shortages, the proposal still has its own share of professionals who might outweigh the negative view of the solution.